Peter Michael Ellis

9PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 26, 2025
A Narrative Review of the Strengths and Limitations of Real-World Evidence in Comparison to Randomized Clinical Trials: What Are the Opportunities in Thoracic Oncology for Real-World Evidence to Shine?

Peter M Ellis, Larissa Long, Courtney H Coschi

|Jun 25, 2025
Cost Disparities with Age in the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) in Ontario, Canada.

Ying Wang, Greg Pond, Amiram Jacob Gafni

|Jun 18, 2025
Perioperative toripalimab and chemotherapy in resectable non-small cell lung cancer: another weapon in the armamentarium.

Courtney H Coschi, Peter M Ellis

|Nov 26, 2024
Update on Practical Management of Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Report from the Ontario Forum.

Parneet K Cheema, Paul F Wheatley-Price, Matthew J Cecchini

|Nov 30, 2023
Molecular Testing in Non-Small-Cell Lung Cancer: A Call to Action.

Arani Sathiyapalan, Peter Michael Ellis

|Oct 11, 2023
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.

Humera Khurshid, Nofisat Ismaila, Jessica Bian

Pageof 2

Frequent Collaborators

1 joint publications

Nofisat Ismaila

1 joint publications

Jessica Bian

1 joint publications

Millie Das

1 joint publications

Christine Hann